
Anuh Pharma Q2 Results FY27: PAT Jumps 47.31% to Rs 11.21 Cr, Revenue Rs 185.24 Cr
Updated: 30 Oct 2026 • 8:15 pm
Posted by:

Quick Answer
Anuh Pharma Q2 Results FY27 were declared on 30 October 2026 on a Standalone basis. Revenue was Rs 185.24 Cr, down 0.34% YoY from Rs 185.88 Cr, and the quarterly results show profit moving the other way. Net profit rose 47.31% to Rs 11.21 Cr from Rs 7.61 Cr, while Operating Profit reached Rs 16.94 Cr.
Anuh Pharma Ltd (ANUHPHR) Q2 Results FY27 announced on 30 October 2026, covering the company's financial performance for the July to September quarter. The results date brought Standalone revenue of Rs 185.24 Cr and PAT of Rs 11.21 Cr, and Anuh Pharma Q2 Results FY27 are now on record with the NSE and BSE as the latest standalone results.
This results analysis of Anuh Pharma Q2 Results looks at the financial highlights, the disclosed business factors, the FY27 outlook and the risks, with Univest data behind each point. The Financial Highlights below compare revenue, Operating Profit and net profit with the same quarter a year earlier.
Click Here – Get Free Investment Predictions
Anuh Pharma Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 185.24 Cr | Rs 185.88 Cr | -0.34% YoY |
| Operating Profit | Rs 16.94 Cr | Rs 11.88 Cr | +42.59% YoY |
| Net Profit (PAT) | Rs 11.21 Cr | Rs 7.61 Cr | +47.31% YoY |
Source: company filing for Anuh Pharma Q2 Results FY27, 30 October 2026. Figures in Rs Crore, Standalone basis.
Key Takeaways from Anuh Pharma Q2 Results: What Stands Out
- Revenue of Rs 185.24 Cr is down 0.34% from Rs 185.88 Cr a year earlier, so sales were close to flat on a YoY growth basis.
- Net profit of Rs 11.21 Cr is up 47.31% from Rs 7.61 Cr, so profit rose even though sales slipped slightly.
- Operating Profit of Rs 16.94 Cr climbed 42.59% from Rs 11.88 Cr, a rise that tracks the gain in net profit.
- Net profit margin of 6.1% in Anuh Pharma Q2 Results FY27 improved from 4.1% in the comparison quarter.
- The performance analysis follows, setting profit growth against the small dip in revenue.
Anuh Pharma Q2 Results FY27: Performance Analysis
Standalone revenue was Rs 185.24 Cr against Rs 185.88 Cr a year ago, a decline of 0.34%. Net profit still moved up from Rs 7.61 Cr to Rs 11.21 Cr, so the quarterly results show earnings growing without a matching rise in sales.
Operating Profit grew 42.59% to Rs 16.94 Cr from Rs 11.88 Cr, close to the 47.31% rise in net profit. In this results analysis, Anuh Pharma Q2 Results FY27 show the two profit lines moving together while the top line stayed almost where it was.
For Anuh Pharma Q2 Results, readers of Anuh Pharma on Univest will want later filings to show whether revenue returns to growth. Profit has risen on a flat base, and the business factors set out what the company disclosed about this quarter.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Net Profit Growth – The business factors start with profit: net profit rose 47.3% year on year to Rs 11.21 Cr. This is the main positive in the quarter, and it came even though revenue was slightly lower.
Margin Improvement – Net profit margin improved to 6.1% from 4.1% in the comparison quarter. In Anuh Pharma Q2 Results FY27, this means each rupee of sales left more profit behind than it did a year earlier.
Capital Returns and Debt – Return on capital employed was 16.02% in FY26, and the company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26. The quarterly results therefore rest on a clean balance sheet.
FY27 Outlook After Anuh Pharma Q2 Results
This outlook is limited to the disclosed numbers. Full-year FY27 results will depend on the quarters still to be reported and on the conditions the company discloses, and the net profit of Rs 11.21 Cr sets the base for that comparison.
In this results analysis, Anuh Pharma Q2 Results FY27 offer one clear reference point: net profit is up 47.31% while revenue is down 0.34%. The Univest app helps readers follow the next filing, and the risks below show where the picture could change.
Key Risks to Watch After Anuh Pharma Q2 Results FY27
Revenue Decline Year on Year
Revenue declined 0.3% year on year to Rs 185.24 Cr in the latest quarter. Readers of Anuh Pharma Q2 Results FY27 should note that profit growth has come without any growth in sales.
Sequential Revenue Dip
Revenue was down 4.4% quarter on quarter from Rs 193.81 Cr. A fall from the prior quarter shows that sales have eased recently, and YoY growth in profit would be harder to hold if that continued.
Sequential Net Profit Dip
Net profit was down 1.8% quarter on quarter from Rs 11.42 Cr. The dip is small, but together with the lower sales it shows that the profit gain over last year has not widened since the previous quarter.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Anuh Pharma Q2 Results FY27 show revenue of Rs 185.24 Cr and net profit of Rs 11.21 Cr on a Standalone basis, with profit higher and sales slightly lower YoY. The quarterly results show a better margin on a flat top line, and Anuh Pharma Q2 Results remain the reference for the standalone results. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Anuh Pharma Q2 Results FY27
What are Anuh Pharma Q2 Results FY27?
Ans. Anuh Pharma Q2 Results FY27 are the July to September 2026 standalone results of Anuh Pharma, with revenue of Rs 185.24 Cr and net profit of Rs 11.21 Cr, as summarised in the quick answer box above.
What is the results date for Anuh Pharma Q2 Results FY27?
Ans. The results date for Anuh Pharma Q2 Results FY27 is 30 October 2026, the day the company declared its quarterly results, which means every Q2 FY27 figure on this page comes from that one filing.
What revenue was reported in Anuh Pharma Q2 Results FY27?
Ans. Anuh Pharma reported Q2 FY27 revenue of Rs 185.24 Cr against Rs 185.88 Cr a year earlier, so the Financial Highlights section shows a small decline of 0.34% on the same quarter.
What net profit was reported in Anuh Pharma Q2 Results FY27?
Ans. Net profit for the quarter was Rs 11.21 Cr against Rs 7.61 Cr in the same quarter last year, which means the performance analysis treats it as the main gain in the results.
How much YoY growth did revenue show in Anuh Pharma Q2 Results FY27?
Ans. Revenue showed YoY growth of negative 0.34% in Q2 FY27, so it dipped slightly, while net profit grew 47.31%, and the performance analysis explains how the two figures differ.
Did net profit rise or fall in Anuh Pharma Q2 Results?
Ans. Anuh Pharma Q2 Results show net profit rising 47.31% to Rs 11.21 Cr from Rs 7.61 Cr, while the key takeaways section places that rise next to the 0.34% dip in revenue.
What was the Operating Profit in Anuh Pharma Q2 Results FY27?
Ans. Operating Profit in Anuh Pharma Q2 Results FY27 was Rs 16.94 Cr, up 42.59% from Rs 11.88 Cr a year ago, so it moved close to net profit, as the performance analysis notes.
Are Anuh Pharma Q2 Results consolidated results or standalone results?
Ans. Anuh Pharma Q2 Results are standalone results because the company declared them on a Standalone basis, so the numbers cover the company alone and match the basis stated in the introduction.
What business factors shaped Anuh Pharma Q2 Results FY27?
Ans. The disclosed factors are net profit growth of 47.3%, a margin that improved to 6.1% and a debt-free balance sheet with 16.02% return on capital employed, so the business factors section covers these.
What are the key risks after Anuh Pharma Q2 Results FY27?
Ans. The risks are a 0.3% year on year revenue decline, a 4.4% quarter on quarter revenue dip and a 1.8% quarter on quarter net profit dip, so the key risks section reviews each.
What is the outlook after Anuh Pharma Q2 Results?
Ans. The FY27 outlook rests on later quarters and disclosed conditions, while the outlook section anchors on the 47.31% net profit growth and the 0.34% revenue dip reported in this quarter.
Where can I find the complete Anuh Pharma Q2 Results FY27 data?
Ans. The complete Anuh Pharma Q2 Results FY27 figures are in the Financial Highlights table on this page and in the exchange filing, while the Univest Screener lets readers compare the company with others.
Recent Articles

Navin Fluorine International Q2 Results FY27: PAT Jumps 37.88% to Rs 204.57 Cr, Revenue Rs 737.26 Cr
30 October 2026

Xchanging Solutions Q2 Results FY27: PAT Falls 6.58% to Rs 15.19 Cr, Revenue Rs 53.21 Cr
30 October 2026

Aditya Birla Capital Q2 Results FY27: PAT Jumps 37.94% to Rs 1,287.68 Cr, Revenue Rs 14,003.21 Cr
30 October 2026

Sun Pharmaceutical Industries Q2 Results FY27: PAT Falls 36.22% to Rs 1,988.53 Cr, Revenue Rs 16,198.71 Cr
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Navin Fluorine International Q2 Results FY27: PAT Jumps 37.88% to Rs 204.57 Cr, Revenue Rs 737.26 Cr
Xchanging Solutions Q2 Results FY27: PAT Falls 6.58% to Rs 15.19 Cr, Revenue Rs 53.21 Cr
Aditya Birla Capital Q2 Results FY27: PAT Jumps 37.94% to Rs 1,287.68 Cr, Revenue Rs 14,003.21 Cr
Sun Pharmaceutical Industries Q2 Results FY27: PAT Falls 36.22% to Rs 1,988.53 Cr, Revenue Rs 16,198.71 Cr
Sambhaav Media Q2 Results FY27: Loss to Profit Swing, Revenue Rs 9.88 Cr, PAT Rs 0.28 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





